An Open-Label, Multicenter Phase I Study to Evaluate the Safety, Efficacy, and Pharmacokinetic Characteristics of Intraperitoneal Perfusion With Docetaxel Polymeric Micelles for Injection in Patients With Malignant Ascites
Latest Information Update: 13 Jun 2025
At a glance
- Drugs Docetaxel (Primary)
- Indications Malignant ascites
- Focus Adverse reactions; Therapeutic Use
- Acronyms SIM0388-101
- Sponsors Jiangsu Simcere Pharmaceutical
Most Recent Events
- 13 Jun 2025 New trial record